Asia-Pacific Vaccines Market to 2032
Overview
The Asia-Pacific Vaccines Market is expected to reach a 19,833.68 USD Billion by 2032 and is projected to grow at a CAGR of 12.74% from 2025 to 2032.
Revenue, 2024 (USD Billion)
10,332.01
Forecast, 2032 (USD Billion)
19,833.68
CAGR, 2024 - 2032
12.74%
Report Coverage
Asia-Pacific
Asia-Pacific Vaccines Market 2018-2032 USD Billion
Asia-Pacific Vaccines Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 10,332.01 USD Billion
- Projected Market Size (2032): 19,833.68 USD Billion
- CAGR (2025-2032): 12.74%
Key Findings of Asia-Pacific Vaccines Market
- The Asia-Pacific Vaccines Market was valued at 10,332.01 USD Billion in 2024.
- The Asia-Pacific Vaccines Market is likely to grow at a CAGR of 12.74% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Injectable in Route of Administration Segment accounted for the largest share of the market with a revenue of 9,172.97 USD Billion
- The fastest growing segment Influenza in Diseases Segment grew Fastest with a CAGR of 14.65% during the forecast period from 2024 to 2032.
Asia-Pacific Vaccines Market Scope
Asia-Pacific Vaccines Market Segmentation & Scope
Kind
- Required Vaccine
- Recommended Vaccines
- Routine Vaccine
Age of Administration
- Adult Vaccines
- Pediatric Vaccines
Type
- DNA Vaccines (Zika Virus)
- Toxoid Vaccines
- Inactivated Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Diseases
- Yellow Fever
- Japanese Encephalitis
- Rabies
- Varicella
- Meningococcal
- Typhoid
- Influenza
- Hepatitis
- DPT
- Measles, Mumps & Rubella
- Pneumoccocal Disease
- Others
Route of Administration
- Nasal
- Oral
- Injectable
End User
- Others
- Clinics
- Specialty Centres
- Hospitals
- Community Hospitals
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
Asia-Pacific Vaccines Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 10,332.01 USD Billion |
| Market Value in 2032 | 19,833.68 USD Billion |
| CAGR (2025-2032) | 12.74% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Kind,Age of Administration,Type,Composition,Diseases,Route of Administration,End User,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): Asia-Pacific, leading in terms of revenue 10,332.01 USD Billion in 2024
- Key Country: Japan, leading in terms of revenue with value of 2,189.19 USD Billion in 2024.
Segments and Scope
-
Asia-Pacific Vaccines Market to 2032, By Kind
- Routine Vaccine is the largest segment in Asia-Pacific Vaccines Market to 2032 with a revenue of 7,023.39 USD Billion in the year 2024.
- Recommended Vaccines is the Fastest growing segment in Asia-Pacific Vaccines Market to 2032 with a Growth rate of 12.26 % in forecast period 2025-2032.
-
Asia-Pacific Vaccines Market to 2032, By Age of Administration
- Pediatric Vaccines is the largest segment in Asia-Pacific Vaccines Market to 2032 with a revenue of 6,167.59 USD Billion in the year 2024.
- Adult Vaccines is the Fastest growing segment in Asia-Pacific Vaccines Market to 2032 with a Growth rate of 12.50 % in forecast period 2025-2032.
-
Asia-Pacific Vaccines Market to 2032, By Type
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines is the largest segment in Asia-Pacific Vaccines Market to 2032 with a revenue of 4,009.02 USD Billion in the year 2024.
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines is the Fastest growing segment in Asia-Pacific Vaccines Market to 2032 with a Growth rate of 13.52 % in forecast period 2025-2032.
-
Asia-Pacific Vaccines Market to 2032, By Composition
- Combination Vaccines is the largest segment in Asia-Pacific Vaccines Market to 2032 with a revenue of 7,965.77 USD Billion in the year 2024.
- Combination Vaccines is the Fastest growing segment in Asia-Pacific Vaccines Market to 2032 with a Growth rate of 13.03 % in forecast period 2025-2032.
-
Asia-Pacific Vaccines Market to 2032, By Diseases
- Pneumoccocal Disease is the largest segment in Asia-Pacific Vaccines Market to 2032 with a revenue of 1,638.99 USD Billion in the year 2024.
- Influenza is the Fastest growing segment in Asia-Pacific Vaccines Market to 2032 with a Growth rate of 13.97 % in forecast period 2025-2032.
-
Asia-Pacific Vaccines Market to 2032, By Route of Administration
- Injectable is the largest segment in Asia-Pacific Vaccines Market to 2032 with a revenue of 9,172.97 USD Billion in the year 2024.
- Injectable is the Fastest growing segment in Asia-Pacific Vaccines Market to 2032 with a Growth rate of 12.83 % in forecast period 2025-2032.
-
Asia-Pacific Vaccines Market to 2032, By End User
- Community Hospitals is the largest segment in Asia-Pacific Vaccines Market to 2032 with a revenue of 6,291.47 USD Billion in the year 2024.
- Specialty Centres is the Fastest growing segment in Asia-Pacific Vaccines Market to 2032 with a Growth rate of 12.46 % in forecast period 2025-2032.
-
Asia-Pacific Vaccines Market to 2032, By Distribution Channel
- Hospital Pharmacy is the largest segment in Asia-Pacific Vaccines Market to 2032 with a revenue of 6,857.95 USD Billion in the year 2024.
- Retail Pharmacy is the Fastest growing segment in Asia-Pacific Vaccines Market to 2032 with a Growth rate of 12.18 % in forecast period 2025-2032.
Asia-Pacific Vaccines Market Company Share Analysis
Asia-Pacific Vaccines Market Geographical Sales Distribution, 2018-2032 USD Billion
Asia-Pacific Vaccines Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Asia-Pacific Vaccines Market is segmented based on Segmentation Kind,Age of Administration,Type,Composition,Diseases,Route of Administration,End User,Distribution Channel.
Asia-Pacific Vaccines Market was valued at USD 10,332.01(Revenue in USD Billion) in 2020.
Asia-Pacific Vaccines Market is projected to grow at a CAGR of 12.74% during the forecast period of 2024 to 2032.
The Injectable segment is expected to dominate the Asia-Pacific Vaccines Market, holding a largest market share of 9,172.97 USD Billion in 2024
Asia-Pacific Vaccines Market Scope
Asia-Pacific Vaccines Market Segmentation & Scope
Kind
- Required Vaccine
- Recommended Vaccines
- Routine Vaccine
Age of Administration
- Adult Vaccines
- Pediatric Vaccines
Type
- DNA Vaccines (Zika Virus)
- Toxoid Vaccines
- Inactivated Vaccines
- Live-Attenuated Vaccines
- Subunit, Recombinant, Polysaccharide, And Conjugate Vaccines
Composition
- Mono Vaccines
- Combination Vaccines
Diseases
- Yellow Fever
- Japanese Encephalitis
- Rabies
- Varicella
- Meningococcal
- Typhoid
- Influenza
- Hepatitis
- DPT
- Measles, Mumps & Rubella
- Pneumoccocal Disease
- Others
Route of Administration
- Nasal
- Oral
- Injectable
End User
- Others
- Clinics
- Specialty Centres
- Hospitals
- Community Hospitals
Distribution Channel
- Online Pharmacy
- Retail Pharmacy
- Hospital Pharmacy
Frequently Asked Questions
The Asia-Pacific Vaccines Market is segmented based on Segmentation Kind,Age of Administration,Type,Composition,Diseases,Route of Administration,End User,Distribution Channel.
Asia-Pacific Vaccines Market was valued at USD 10,332.01(Revenue in USD Billion) in 2020.
Asia-Pacific Vaccines Market is projected to grow at a CAGR of 12.74% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Vaccines Market for final year is USD 19,833.68 (USD Billion).
Asia-Pacific Vaccines Market Company Profiling
Frequently Asked Questions
The Asia-Pacific Vaccines Market is segmented based on Segmentation Kind,Age of Administration,Type,Composition,Diseases,Route of Administration,End User,Distribution Channel.
Asia-Pacific Vaccines Market was valued at USD 10,332.01(Revenue in USD Billion) in 2020.
Asia-Pacific Vaccines Market is projected to grow at a CAGR of 12.74% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Vaccines Market for final year is USD 19,833.68 (USD Billion).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.